![Stefanie Flückiger-Mangual](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stefanie Flückiger-Mangual
Amministratore Delegato presso TOLREMO therapeutics AG
Profilo
Stefanie Flückiger-Mangual is the founder and current Chief Executive Officer & Director of TOLREMO therapeutics AG, which is founded in 2017.
Posizioni attive di Stefanie Flückiger-Mangual
Società | Posizione | Inizio |
---|---|---|
TOLREMO therapeutics AG
![]() TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland. | Amministratore Delegato | 01/03/2017 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
TOLREMO therapeutics AG
![]() TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland. | Commercial Services |
- Borsa valori
- Insiders
- Stefanie Flückiger-Mangual